Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002479 · ClinicalTrials.gov registry record · Phase 2
Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002479: Completed Phase 2 study, sponsored by Northwestern University.
NCT00002479 is a Phase 2 study that has completed, run by Northwestern University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002479, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of tretinoin in treating patients who have any stage mycosis fungoides or Sezary syndrome.
Interventions
- DRUG tretinoin
Trial Details
| Field | Value |
|---|---|
| Start Date | 1991-10 |
| Est. Completion | 2002-08 |
| Phase | Phase 2 |
What the finished NCT00002479 record still lists
NCT00002479 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which tretinoin is the first listed.
NCT00002479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002479 about?
NCT00002479 is a clinical study titled "Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of tretinoin in treating patients who have any stage mycosis fungoides or Sezary syndrome.
What is the current status of trial NCT00002479?
This trial is currently completed. It is a Phase 2 study. The study started on 1991-10. Estimated completion is 2002-08.
What interventions are being tested in trial NCT00002479?
The interventions under investigation include: tretinoin (DRUG).
Who is sponsoring clinical trial NCT00002479?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia